After a stormy courtship lasting two years, Britain’s two biggest drugs
companies have finally agreed to tie the knot and create the world’s largest
pharmaceuticals company. Glaxo Wellcome and SmithKline Beecham plan to merge to
form Glaxo SmithKline, a monster with a research and development budget of
£2.4 billion. A key reason for the merger is to speed up the development
of new drugs by unravelling the genetic causes of diseases. Both companies say
that job losses are inevitable, but research staff aren’t expected to bear the
brunt.
To continue reading, today with our introductory offers
Advertisement
More from ¿ìè¶ÌÊÓÆµ
Explore the latest news, articles and features

Physics
Photons behave very strangely if you try to cut them
¿ìè¶ÌÊÓÆµ

Mathematics
Aim high but don't shoot for the moon, mathematicians advise
¿ìè¶ÌÊÓÆµ

Technology
Horror video game gets its creepiness from a quantum computer
¿ìè¶ÌÊÓÆµ

Mind
We're becoming more individualistic and it's affecting our love lives
¿ìè¶ÌÊÓÆµ
Popular articles
Trending ¿ìè¶ÌÊÓÆµ articles
1
Pancreatic cancer halted by virus injection in three patients
2
Glaciers in the 'roof of the world' have suddenly started melting
3
Does gravity create reality? A shocking path to a theory of everything
4
Wealthy people with environmental ideals are the biggest emitters
5
Aim high but don't shoot for the moon, mathematicians advise
6
Mathematical AI helps researchers crack 50-year-old problem
7
Embryos made without sperm or eggs reveal why many pregnancies fail
8
Q-Day could destroy bitcoin – and our retirement savings
9
PCOS has been officially renamed PMOS, and it’s a momentous move
10
The ‘doomsday’ glacier’s giant ice shelf is about to break away